Project Details
Description
Project Narrative
The central premise of this project is that a comprehensive analysis of both the infecting organism
and the host response that is activated, can be used to direct immunomodulatory therapy that will
improve outcomes of severe bacterial pneumonia.
| Status | Finished |
|---|---|
| Effective start/end date | 1/11/17 → 11/30/22 |
Funding
- National Heart, Lung, and Blood Institute: US$705,002.00
- National Heart, Lung, and Blood Institute: US$79,028.00
- National Heart, Lung, and Blood Institute: US$775,311.00
ASJC Scopus Subject Areas
- Microbiology
- Pulmonary and Respiratory Medicine
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.